Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer (Q38738099)

6 September 2017

Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer (English)

1 reference

6 September 2017

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Brunella Costanza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Edwin De Pauw

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Andrei Turtoi

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

A Blomme

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

P de Tullio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

M Thiry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

G Van Simaeys

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

S Boutry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

G Doumont

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

E Di Valentin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

T Hirano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

T Yokobori

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

S Gofflot

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

A Bellahcène

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

F Sherer

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

C Le Goff

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

E Cavalier

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

A Mouithys-Mickalad

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

F Jouret

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

P G Cusumano

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

E Lifrange

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

R N Muller

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

S Goldman

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

P Delvenne

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

M Nishiyama

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

V Castronovo

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

24 October 2016

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

2116-2130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27775075%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2016.369

3 June 2020

exact match

0 references

cites work

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

New strategies for triple-negative breast cancer--deciphering the heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Therapeutic targets in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Targeting cancer metabolism: a therapeutic window opens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

The genomic analysis of lactic acidosis and acidosis response in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Endocytosis and signalling: intertwining molecular networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Chemistry and biology of eukaryotic iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Reciprocal regulation of endocytosis and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Lipid homeostasis, lipotoxicity and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Myoferlin is a key regulator of EGFR activity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Loss of myoferlin redirects breast cancer cell motility towards collective migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Self-antigen recognition by follicular lymphoma B-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Myoferlin is critical for endocytosis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Caveolae and the regulation of endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Effects of fatty acids on mitochondria: implications for cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Normal myoblast fusion requires myoferlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Lipid compartmentalization in the endosome system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

The Emerging Hallmarks of Cancer Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

A mitochondrial switch promotes tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

An easy, convenient cell and tissue extraction protocol for nuclear magnetic resonance metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.369

The early endosome: a busy sorting station for proteins at the crossroads.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27775075